News
06-07-2012, 02:15 AM
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that results of a prospective, 155-patient trial reinforce the value of the Microvolt T-Wave Alternans (MTWA) test as a predictor of life-threatening heart rhythms and Sudden Cardiac Death (SCD).
More... (http://www.news-medical.net/news/20120607/New-data-supports-clinical-role-of-Cambridge-Hearte28099s-MTWA-test-in-managing-patients-at-risk-of-SCA.aspx)
More... (http://www.news-medical.net/news/20120607/New-data-supports-clinical-role-of-Cambridge-Hearte28099s-MTWA-test-in-managing-patients-at-risk-of-SCA.aspx)